Back to GAMCO Investors, Inc. GAMCO Investors, Inc.

HBIO

8 quarters

Position history for GAMCO Investors, Inc.GAMCO Investors, Inc.'s holdings in Harvard Bioscience, Inc.

As of its Q4 2025 13F, GAMCO Investors held 57,000 shares of HBIO (Harvard Bioscience), worth $38,122.

Final Value

$0

Final Shares

0

Total Value Change

-$42,750

Total Shares Change

-15,000

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Exited
0
-100.0%
$00.0%$4.87
0
2025-Q4
New
57,000
-
$38,1220.0%$6.70
28
2025-Q3
Exited
0
-100.0%
$00.0%$4.40
0
2025-Q2
Decreased
77,000
-9.4%
$34,1730.0%$4.40
0
2025-Q1
Decreased
85,000
-10.5%
$48,1100.0%$5.70
0
2024-Q4
New
95,000
-
$200,4500.0%$21.10
32
2024-Q3
Exited
0
-100.0%
$00.0%$26.90
0
2024-Q2
New
15,000
-
$42,7500.0%$28.50
28

Other major holders of HBIO: Royce & Associates LP, Dimensional Fund Advisors LP, BlackRock Finance, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used